3年虚增利润6.5亿，苗药龙头被ST，罚款1000万

Group 1 - The core issue involves Guizhou BaiLing's financial misconduct, where the company is accused of falsely reporting financial data in its periodic reports, leading to inflated profits of 654.726 million yuan from 2019 to 2021 and a reduction of profits by 459.411 million yuan in 2023 [1] - The Guizhou Securities Regulatory Bureau has proposed administrative penalties against Guizhou BaiLing, including a fine of 10 million yuan and warnings to 10 responsible individuals, including a 10-year market ban for Jiang Wei [1] - Following the announcement of the penalties, Guizhou BaiLing's stock will be subject to additional risk warnings by the Shenzhen Stock Exchange due to the false disclosures in its annual reports [1] Group 2 - Guizhou BaiLing's stock will be suspended for one day starting December 22, 2025, and will resume trading on December 23, 2025, with a change in its stock name to "ST BaiLing" while retaining the same stock code [2] - As of December 19, 2023, Guizhou BaiLing's stock price was 5.63 yuan, with a total market capitalization of 7.9 billion yuan, reflecting an increase of over 46% year-to-date [3]